BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19711075)

  • 21. Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemia.
    Orleans-Lindsay JK; Barber LD; Prentice HG; Lowdell MW
    Clin Exp Immunol; 2001 Dec; 126(3):403-11. PubMed ID: 11737054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.
    Zhong RK; Lane TA; Ball ED
    Exp Hematol; 2008 Apr; 36(4):486-94. PubMed ID: 18249062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human acute lymphoblastic leukemia (ALL) blasts as accessory cells during T-cell activation: differences between patients in costimulatory capacity affect proliferative responsiveness and cytokine release by activated T cells.
    Bruserud O; Ulvestad E
    Cancer Immunol Immunother; 2003 Apr; 52(4):215-25. PubMed ID: 12669246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-13 secretion by normal and posttransplant T lymphocytes; in vitro studies of cellular immune responses in the presence of acute leukaemia blast cells.
    Bruserud O; Pawelec G
    Cancer Immunol Immunother; 1997 Oct; 45(1):45-52. PubMed ID: 9353426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Core-binding factor-beta positive acute myeloid leukaemia cells induce T-cell responses.
    Banat GA; Ihlow K; Usluoglu N; Hoppmann S; Hoeck M; Pralle H
    Br J Haematol; 2003 Dec; 123(5):819-29. PubMed ID: 14632772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A bispecific antibody enhances cytokine-induced killer-mediated cytolysis of autologous acute myeloid leukemia cells.
    Kaneko T; Fusauchi Y; Kakui Y; Masuda M; Akahoshi M; Teramura M; Motoji T; Okumura K; Mizoguchi H; Oshimi K
    Blood; 1993 Mar; 81(5):1333-41. PubMed ID: 8095165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Interferon (IFN)α in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions.
    Hirn Lopez A; Deen D; Fischer Z; Rabe A; Ansprenger C; Stein K; Vogt V; Schick J; Kroell T; Kraemer D; Kolb HJ; Tischer J; Schmid C; Schmetzer H
    J Immunother; 2019 Jun; 42(5):143-161. PubMed ID: 31090655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic effectors activated by low-dose IL-2 plus IL-12 lyse IL-2-resistant autologous acute myeloid leukaemia blasts.
    Vitale A; Guarini A; Latagliata R; Cignetti A; Foa R
    Br J Haematol; 1998 Apr; 101(1):150-7. PubMed ID: 9576195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective targeting of human lymphokine-activated killer cells by CD3 monoclonal antibody against the interferon-inducible high-affinity Fc gamma RI receptor (CD64) on autologous acute myeloid leukemic blast cells.
    Notter M; Ludwig WD; Bremer S; Thiel E
    Blood; 1993 Nov; 82(10):3113-24. PubMed ID: 7693036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia.
    Musuraca G; De Matteis S; Napolitano R; Papayannidis C; Guadagnuolo V; Fabbri F; Cangini D; Ceccolini M; Giannini MB; Lucchesi A; Ronconi S; Mariotti P; Savini P; Tani M; Fattori PP; Guidoboni M; Martinelli G; Zoli W; Amadori D; Carloni S
    J Transl Med; 2015 Jul; 13():229. PubMed ID: 26174551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transduction of acute myeloid leukemia cells with third generation self-inactivating lentiviral vectors expressing CD80 and GM-CSF: effects on proliferation, differentiation, and stimulation of allogeneic and autologous anti-leukemia immune responses.
    Koya RC; Kasahara N; Pullarkat V; Levine AM; Stripecke R
    Leukemia; 2002 Sep; 16(9):1645-54. PubMed ID: 12200676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
    Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
    Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission.
    Whiteway A; Corbett T; Anderson R; Macdonald I; Prentice HG
    Br J Haematol; 2003 Feb; 120(3):442-51. PubMed ID: 12580958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage.
    Re F; Arpinati M; Testoni N; Ricci P; Terragna C; Preda P; Ruggeri D; Senese B; Chirumbolo G; Martelli V; Urbini B; Baccarani M; Tura S; Rondelli D
    Exp Hematol; 2002 Feb; 30(2):126-34. PubMed ID: 11823047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine.
    Shawler DL; Bartholomew RM; Garrett MA; Trauger RJ; Dorigo O; Van Beveren C; Marchese A; Ferre F; Duffy C; Carlo DJ; Sherman LA; Gold DP; Sobol RE
    Clin Exp Immunol; 2002 Jul; 129(1):99-106. PubMed ID: 12100028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia.
    Memarian A; Nourizadeh M; Masoumi F; Tabrizi M; Emami AH; Alimoghaddam K; Hadjati J; Mirahmadian M; Jeddi-Tehrani M
    Tumour Biol; 2013 Feb; 34(1):531-42. PubMed ID: 23179394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
    Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
    J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts: studies of allostimulated interferon-gamma secretion.
    Bruserud O; Mentzoni L; Foss B; Bergheim J; Berentsen S; Nesthus I
    Cancer Immunol Immunother; 1996 Dec; 43(5):275-82. PubMed ID: 9024504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Induction of efficient T-cell immunity against autologous leukemia cells by dendritic cells pulsed with the leukemia cell total RNA].
    Ge W; You SG; Wang YF; Li CH; Liu XF; He XP; Ma S; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):461-4. PubMed ID: 16383235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1.
    Hirst WJ; Buggins A; Darling D; Gäken J; Farzaneh F; Mufti GJ
    Gene Ther; 1997 Jul; 4(7):691-9. PubMed ID: 9282170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.